New skin cancer treatment cuts death risk

A study has shown that a new treatment based on an mRNA vaccine, given alongside an immunotherapy drug, reduces the risk of skin cancer recurrence by 49% after surgical removal in advanced stages. Researchers conducted trials on 157 patients and confirmed the therapy's effectiveness and durability, with only mild side effects. The treatment is still in the final stages of clinical trials before widespread approval.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل